ArticleJACC. Case reports2025
First Transcatheter Pulmonary Valve Replacement in Tanzania: Feasibility of Advanced Cardiac Interventions in Resource-Limited Settings.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranscatheter pulmonary valve implantation (TPVI) has emerged as a viable alternative to surgical pulmonary valve replacement for patients with congenital heart disease and right ventricular outflow tract dysfunction. However, its adoption in low-resource settings has been limited. CASE SUMMARY: We report the first successful TPVI procedures in Tanzania. Case 1 involved a 16-year-old male with Noonan syndrome and prior homograft conduit for pulmonary atresia and ventricular septal defect. Case 2 was a 16-year-old female with repaired Tetralogy of Fallot who had undergone prior surgical valve replacement with a Trifecta valve. Both patients presented with severe right ventricular outflow tract dysfunction and underwent successful TPVI with a 20-mm Melody valve (Medtronic) without complications. Postprocedural imaging confirmed hemodynamic improvement and symptom relief. DISCUSSION: These first-in-country cases demonstrate the feasibility of TPVI in resource-limited settings. Broader implementation will require cost-reduction strategies, industry collaboration, and provider training to overcome financial and technical barriers. TAKE-HOME MESSAGE: TPVI can be safely implemented in low- and middle-income countries through structured planning and partnerships.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.